Firefly Neuroscience (AIFF) Cost of Revenue (2010 - 2026)

Firefly Neuroscience has reported Cost of Revenue for 16 years, with the latest figure at $261000.0 in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 944.0% year-over-year to $261000.0 in Q2 2026; TTM through Jun 2026 was $997000.0, a 3888.0% increase from a year earlier, with the FY2025 full-year figure at $497000.0, changed N/A from the prior year.
• Cost of Revenue was $261000.0 for Q2 2026 at Firefly Neuroscience, down from $264000.0 in the prior quarter.
• The five-year high for Cost of Revenue was $2.8 million in Q2 2022, with the low at $25000.0 in Q2 2025.
• Average Cost of Revenue over 5 years is $1.1 million, with a median of $1.3 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Cost of Revenue sank 53.64% in 2023, then jumped 944.0% in 2026.
• Over 5 years, Cost of Revenue stood at $1.4 million in 2022, then retreated by 15.16% to $1.2 million in 2023, then slipped by 0.91% to $1.2 million in 2024, then plunged by 81.09% to $230000.0 in 2025, then gained by 13.48% to $261000.0 in 2026.
• The last three Cost of Revenue figures came in at $261000.0 (Q2 2026), $264000.0 (Q1 2026), and $230000.0 (Q4 2025), per Business Quant data.